In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling.
Germain A, et al. (2021) In-Depth Analysis of the Plasma […]
Research Papers
Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.
Gonz�lez-Cebri�n A, et al. (2022) Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue
Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE).
Gottschalk G, et al. (2022) Elevated ATG13 in serum of
A gene signature for post-infectious chronic fatigue syndrome.
A gene signature for post-infectious chronic fatigue syndrome. Read More »
Gow JW, et al. (2009) A gene signature for post-infectious
Review of the Quality Control Checks Performed by Current Genome-Wide and Targeted-Genome Association Studies on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Grabowska A, et al. (2020) Review of the Quality Control
A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
Corbitt M, et al. (2018) A Systematic Review of Probiotic
Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.
Giloteaux L, et al. (2016) Reduced diversity and altered composition
Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS.
Guo C et al . (2023) Deficient butyrate-producing capacity in
No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after
Hanevik K, et al. (2022) No difference in serum levels
A Retrospective Outcome Study of 42 Patients with Chronic Fatigue Syndrome, 30 of Whom had Irritable Bowel Syndrome. Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation.
Kenyon J, et al. (2019) A Retrospective Outcome Study of
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). Read More »
K�nig RS, et al . (2022) The Gut Microbiome in
Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
Lupo GFD, et al. (2021) Potential role of microbiome in
Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome.
Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome. Read More »
Mandarano AH, et al. (2018) Eukaryotes in the gut microbiota
Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Nagy-Szakal D, et al. (2017) Fecal metagenomic profiles in subgroups
Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
Newberry F, et al. (2018) Does the microbiome and virome
Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.
Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome. Read More »
Ostojic SM (2021) Diagnostic and Pharmacological Potency of Creatine in
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity,
Proal AD and Marshall T (2018) Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review.
Roman P, et al. (2018) Are probiotic treatments useful on